Elisabeth Leiderman
Signal active
Chief Financial Officer & Chief Business Officer
Contact Information
Social
Primary Organization
Atsena Therapeutics
Founded
2019
Employees
11-50
Industry
Biotechnology, Health Care, Therapeutics
Bio
Elisabeth Leiderman is the Chief Financial Officer and Chief Business Officer of Atsena Therapeutics. She previously worked at Decibel Therapeutics as a Chief Financial Officer & Head of Corporate Development. Elisabeth Leiderman attended The Wharton School.
Location
New York, New York, United States, North America
Jobs history
5
WIB
Executive Women in Bio 2019 Board Room Ready Member
2019 - Current
Bluebird Bio
Board of Directors and Audit Committee Chair
2021 - Current
Atsena Therapeutics
Chief Financial Officer & Chief Business Officer
2022 - Current
Complexa
Chief Business Officer
2020 - 2020
Decibel Therapeutics
CFO
2020 - 2022
Educations
2
The Wharton School
Finance and Healthcare Management
University of Pennsylvania
Biological Sciences
Profile Resume
Elisabeth Leiderman is the Chief Financial Officer & Chief Business Officer at Atsena Therapeutics, based in New York, New York, United States, North America. With a background in Biotechnology, Elisabeth Leiderman has a rich history of leadership and innovation.Elisabeth Leiderman studied MBA Finance and Healthcare Management at The Wharton School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.